| Literature DB >> 2907521 |
A Cournot1, I Berlin, J C Sallord, E Singlas.
Abstract
Nizatidine is a new antagonist of H2 receptors. The nizatidine warfarin interaction was investigated in healthy volunteers during chronic warfarin (mean warfarin dose: 5 +/- 0.9 mg/d) and nizatidine (300 mg/d) administration. Nizatidine coadministration did not increase the prothrombin time, kaolin-cephalin clotting time, and did not modify the activity of clotting factors II, VII, IX, X. Nizatidine did not influence the steady-state plasma warfarin concentration.Entities:
Mesh:
Substances:
Year: 1988 PMID: 2907521 DOI: 10.1002/j.1552-4604.1988.tb05727.x
Source DB: PubMed Journal: J Clin Pharmacol ISSN: 0091-2700 Impact factor: 3.126